Mirae Asset Global Investments
LAB icon

Mirae Asset Global Investments’s Standard BioTools LAB Stock Holding History

Mirae Asset Global Investments’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-27,889
Closed -$71K – 1497
2020
Q1 		$71K Buy
27,889
+3,159
+13% +$10.4K ﹤0.01% 1394
2019
Q4 		$86K Buy
24,730
+2,283
+10% +$8.03K ﹤0.01% 1461
2019
Q3 		$104K Buy
+22,447
New +$177K ﹤0.01% 1411

Other funds holding LAB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ICM
Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

Mirae Asset Global Investments's LAB Position: Q2 2020 in Review

Mirae Asset Global Investments sold out of Standard BioTools (LAB) in Q2 2020, closing a stake of 27,889 shares — an estimated $71K sold.

Mirae Asset Global Investments first reported a position in LAB in Q3 2019 and held it in 3 quarters. The position peaked at $104K in Q3 2019. 112 funds tracked by Wall St. Rank hold LAB as of Q2 2020.

  • Mirae Asset Global Investments reported no remaining Standard BioTools position as of Q2 2020 after selling out during the quarter.
  • Mirae Asset Global Investments sold 27,889 Standard BioTools shares in Q2 2020, an estimated $71K.
  • Mirae Asset Global Investments first reported a position in Standard BioTools in Q3 2019 and held it in 3 quarters.
  • Mirae Asset Global Investments's Standard BioTools position peaked at $104K in Q3 2019.
  • 112 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2020.

Based on Mirae Asset Global Investments's 13F filing for Q2 2020, filed 11 Aug 2020.